Innopharmax Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innopharmax Inc

Watchlist Manager

Watchlist

Price: 11.25 TWD 0.45% Market Closed

Market Cap: NT$1.3B

I	Innopharmax Inc TPEX:4172	TW
C	China Railway Hi-tech Industry Corp Ltd SSE:600528	CN
C	Corfacts Inc OTC:CFCC	US
M	McLaren Resources Inc F:3ML	CA
	Var Energi ASA F:J4V	NO
	Green Minerals AS F:5IP	NO
	Banca Profilo SpA F:BPA	IT
C	Cafom SA F:CAA	FR
C	Chernan Metal Industrial Corp TPEX:3631	TW
	Vitality Products Inc OTC:VPRIF	CA

Profitability Summary

Innopharmax Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

31%

Sustainable 3Y Average Gross Margin

47%

Gross Margin is Increasing

23% > 31%

Negative Operating Margin

-178%

Negative 3Y Average Operating Margin

-213%

Declining Operating Margin

-147% > -178%

Negative Net Margin

-192%

Negative 3Y Average Net Margin

-224%

Declining Net Margin

-171% > -192%

Negative Free Cash Flow Margin

-179%

Negative 3Y Average Free Cash Flow Margin

-177%

Declining Free Cash Flow Margin

-120% > -179%

Negative ROE

-22%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-25%

Declining ROIC

-20% > -30%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.